Standard Biotools (LAB) EBT Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Standard Biotools | 448.37 Mn | -6.80 Mn | 11.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -663.00 |
| Dec 31, 2025 | 23,362.00 |
| Sep 30, 2025 | -15,261.00 |
| Jun 30, 2025 | -2,967.00 |
| Mar 31, 2025 | 42,126.00 |
| Dec 31, 2024 | 19,641.00 |
| Sep 30, 2024 | -4,566.00 |
| Jun 30, 2024 | -6,012.00 |
| Mar 31, 2024 | 1,410.00 |
| Dec 31, 2023 | 11,970.00 |
| Sep 30, 2023 | -2,896.00 |
| Jun 30, 2023 | 172.00 |
| Mar 31, 2023 | -885.00 |
| Dec 31, 2022 | 3,042.00 |
| Sep 30, 2022 | -5,012.00 |
| Jun 30, 2022 | -27,271.00 |
| Mar 31, 2022 | -21,566.00 |
| Sep 30, 2021 | 3,701.00 |
| Jun 30, 2021 | 1,279.00 |
| Mar 31, 2021 | 870.00 |
| Dec 31, 2020 | 439.00 |
| Sep 30, 2020 | 1,796.00 |
| Jun 30, 2020 | -17.00 |
| Mar 31, 2020 | -47,541.00 |
| Dec 31, 2019 | -268.00 |
| Sep 30, 2019 | -410.00 |
| Jun 30, 2019 | -281.00 |
| Mar 31, 2019 | -1,618.00 |
| Dec 31, 2018 | -2,442.00 |
| Sep 30, 2018 | -3,041.00 |
| Jun 30, 2018 | -3,917.00 |
| Mar 31, 2018 | -3,298.00 |
| Dec 31, 2017 | -1,463.00 |
| Sep 30, 2017 | -3,539.00 |
| Jun 30, 2017 | -3,891.00 |
| Mar 31, 2017 | -1,358.00 |
| Dec 31, 2016 | -5,259.00 |
| Sep 30, 2016 | -4,839.00 |
| Jun 30, 2016 | -236.00 |
| Mar 31, 2016 | 1,264.00 |
| Dec 31, 2015 | -984.00 |
| Sep 30, 2015 | 78,200.00 |
| Jun 30, 2015 | 414.00 |